Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alfa-2b”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00004196
What this trial is testing

Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis

Who this might be right for
Melanoma (Skin)
University of Alabama at Birmingham 3,000
Large-scale testing (Phase 3)Study completedNCT01889433
What this trial is testing

An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C

Who this might be right for
HepatitisHepatitis C
Biocad 170
Post-approval studies (Phase 4)UnknownNCT01731301
What this trial is testing

A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)

Who this might be right for
Chronic Hepatitis CEnd Stage Renal Disease
Liver Institute of Virginia 20
Testing effectiveness (Phase 2)Study completedNCT01140997
What this trial is testing

Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Xiamen Amoytop Biotech Co., Ltd. 211
Testing effectiveness (Phase 2)Study completedNCT00030342
What this trial is testing

Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer

Who this might be right for
Colorectal CancerKidney Cancer
St. Luke's Medical Center 60
Large-scale testing (Phase 3)Ended earlyNCT03547154
What this trial is testing

Polyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026)

Who this might be right for
Chronic Myelogenous Leukemia
Merck Sharp & Dohme LLC 344
Testing effectiveness (Phase 2)UnknownNCT02568241
What this trial is testing

Interferon-α After DLI for the Prevention of Relapse

Who this might be right for
Leukemia
Peking University People's Hospital 42
Large-scale testing (Phase 3)Study completedNCT00624325
What this trial is testing

Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 30
Testing effectiveness (Phase 2)Ended earlyNCT00098618
What this trial is testing

Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaPapillary Renal Cell CarcinomaRecurrent Renal Cell Cancer+2 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)UnknownNCT01502696
What this trial is testing

Adjuvant PEG Intron in Ulcerated Melanoma

Who this might be right for
Ulcerated Melanomas
European Organisation for Research and Treatment of Cancer - EORTC 1,200
Testing effectiveness (Phase 2)Ended earlyNCT00176527
What this trial is testing

Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
University of Medicine and Dentistry of New Jersey 40
Large-scale testing (Phase 3)Study completedNCT01740089
What this trial is testing

Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C

Who this might be right for
HepatitisHepatitis C
Biocad 150
Early research (Phase 1)Ended earlyNCT00791271
What this trial is testing

Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT01370642
What this trial is testing

Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 294
Testing effectiveness (Phase 2)Study completedNCT00528528
What this trial is testing

An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants

Who this might be right for
Chronic Hepatitis C
Tibotec BVBA 166
Testing effectiveness (Phase 2)Looking for participantsNCT05731245
What this trial is testing

Ropeginterferon Alfa 2b for Early MyelofibrosisDIPSS Low/Intermediate-1 Risk Myelofibrosis

Who this might be right for
Pre-fibrotic Myelofibrosis
National Taiwan University Hospital 50
Early research (Phase 1)Ended earlyNCT00589550
What this trial is testing

PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Thomas Olencki 1
Testing effectiveness (Phase 2)Study completedNCT02343224
What this trial is testing

Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas

Who this might be right for
Juvenile Pilocytic AstrocytomasOptic Pathway Gliomas
Emory University 9
Large-scale testing (Phase 3)Study completedNCT00686790
What this trial is testing

Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)

Who this might be right for
Hepatitis D, ChronicHepatitis B, Chronic
Merck Sharp & Dohme LLC 68
Testing effectiveness (Phase 2)Ended earlyNCT00085384
What this trial is testing

PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
M.D. Anderson Cancer Center 30
Next Page